354 results on '"Kume, Akihiro"'
Search Results
2. Data from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
3. Supplementary Materials and Methods from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
4. Supplementary Figure 3 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
5. Supplementary Figure 4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
6. Supplementary Figure 2 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
7. Supplementary Figure Legends 1-4 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
8. Supplementary Figure 1 from NF-κB Activity Regulates Mesenchymal Stem Cell Accumulation at Tumor Sites
9. Comprehensive Metabolomic Analysis of IDH1R132H Clinical Glioma Samples Reveals Suppression of β-oxidation Due to Carnitine Deficiency
10. The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs
11. Efficient Gene Transduction in Pigs and Macaques with the Engineered AAV Vector AAV.GT5 for Hemophilia B Gene Therapy
12. Gene Therapy for Parkinson’s Disease Using Aav Vectors
13. Nitric Oxide Synthase Gene Transfer Inhibits Protein Synthesis of Rat Cardiac Mycocytes
14. Basic Studies Toward Hematopoietic Stem Cell Gene Therapy
15. Gene Therapy of a Rodent Model of Parkinson’s Disease using Adeno-Associated Virus (AAV) Vectors
16. A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis
17. Consistent and Robust Factor IX Expression in NAb-negative Macaques by IV Administration of AAV8 Vector: OR-69.
18. ENGINEERED T LYMPHOCYTES EXPRESSING AN ANTI-CD19 CAR SPECIFICALLY ERADICATE B-LYMPHOMA CELLS: OR-60.
19. Trichostatin A sensitizes apoptosis induced by soluble TRAIL-expressing MSCs: OR-36.
20. INTERLEUKIN-10 PREVENTS THE PROGRESSION OF PERITONEAL FIBROSIS: OR-15.
21. GENE THERAPY FOR PHENYLKETONURIA: S8-2.
22. AADC GENE THERAPY FOR PARKINSONʼS DISEASE: FOUR YEARS OF FOLLOW-UP: BP-4.
23. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells
24. A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis
25. Separate control of rep and cap expression using mutant and wild-type LoxP sequences and improved packaging system for adeno-associated virus vector production
26. Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3
27. Selective Expansion of Transduced Cells for Hematopoietic Stem Cell Gene Therapy
28. Targeted Integration of Foreign DNA Into a Defined Locus on Chromosome 19 in K562 Cells Using AAV-Derived Components
29. γ-Rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk/ganciclovir on cancer cells
30. Adeno-Associated Virus-Mediated Transfer of Endothelial Nitric Oxide Synthase Gene Inhibits Protein Synthesis of Rat Ventricular Cardiomyocytes
31. A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer
32. Development of a mouse model for lymph node metastasis with endometrial cancer
33. Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector
34. Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
35. Targeted Insertion of Transgene into a Specific Site on Chromosome 19 by Using Adeno-Associated Virus Integration Machinery
36. CBMS-05 COMPREHENSIVE METABOLOMIC ANALYSIS OF IDH1R132H CLINICAL GLIOMA SAMPLES REVEALS SUPPRESSION OF Β-OXIDATION DUE TO CARNITINE DEFICIENCY
37. 91. TUMOR TRACKING AND THERAPEUTIC GENE AMPLIFICATION BY USING RETROVIRAL VECTOR-PRODUCING MESENCHYMAL STEM CELLS FOR REINFORCEMENT OF SUICIDE CANCER GENE THERAPY
38. 30. SAFETY OF INTRACRANIAL AAV VECTOR INJECTION IN CYNOMOLGUS MONKEYS
39. 20. TOWARDS CLINICAL GENE THERAPY FOR CHRONIC GRANULOMATOUS DISEASE: OPTIMIZATION OF GENE TRANSDUCTION INTO HEMATOPOIETIC STEM/ PROGENITOR CELLS
40. 27. PREVALENCE OF NEUTRALIZING ANTIBODY AGAINST AAV SEROTYPES 1, 8 AND 9 IN CYNOMOLGUS MONKEY COLONIES
41. 4. EFFICIENT AND STABLE LIVER TRANSDUCTION BY A SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS VECTOR FOR PHENYLKETONURIA GENE THERAPY
42. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats
43. Efficacy and safety of topical OPA-15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double-blind, placebo-controlled study
44. Gene Therapy with Virus Vectors for specific Disease of the Nervous System
45. Gene Therapy for Parkinson’s Disease Using Aav Vectors
46. [22] Adeno-associated viral vector-mediated gene therapy of ischemia-induced neuronal death
47. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer
48. Gene therapy for chronic granulomatous disease
49. Allergic contact dermatitis due to diclofenac and indomethacin
50. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.